Role of pore-forming toxins in neonatal sepsis

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Sonnen, Andreas F P ^a   Henneke, Philipp ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM10 ENDOPEPTIDASE; ALPHA HEMOLYSIN; BACTERIAL PROTEIN; BACTERIAL TOXIN; BETA HEMOLYSIN; CRYOPYRIN; CYTOLYSIN; CYTOLYSIN A; GAMMA HEMOLYSIN; HEMOLYSIN; INFLAMMASOME; LEUKOCIDIN; LISTERIOLYSIN; LISTERIOLYSIN O; MEMBRANE PROTEIN; PAXILLIN; PERFORIN; PNEUMOLYSIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR; PORE FORMING CYTOTOXIC PROTEIN;

ALPHA HELIX; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; BACTERIAL MEMBRANE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BETA SHEET; BLOOD BRAIN BARRIER; CELL DAMAGE; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; CHANNEL GATING; CLOSTRIDIUM TETANI; CYTOLYSIS; DISEASE COURSE; EFFECTOR CELL; EPITHELIUM CELL; ERYTHROCYTE; ESCHERICHIA COLI; GROUP B STREPTOCOCCAL INFECTION; HUMAN; HYDROPHILICITY; IMMUNE SYSTEM; INFLAMMATION; LISTERIA MONOCYTOGENES; LISTERIOSIS; MACROPHAGE; MEDIATOR; NEWBORN SEPSIS; NONHUMAN; PATHOGENESIS; PHAGOCYTE; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; SYMPTOM; TARGET CELL; X RAY CRYSTALLOGRAPHY; BIOSYNTHESIS; CELL MEMBRANE; CHEMISTRY; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; GRAM POSITIVE BACTERIUM; GRAM POSITIVE INFECTION; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; NEWBORN; NEWBORN DISEASE; PATHOGENICITY; PATHOLOGY; PROTEIN SECONDARY STRUCTURE; SEPSIS;

CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; PORE FORMING CYTOTOXIC PROTEINS; PROTEIN STRUCTURE, SECONDARY; SEPSIS; VIRULENCE FACTORS;

EID: 84877955628     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/608456     Document Type: Review

References (165)

1. Verstraelen H., Swidsinski A., The biofilm in bacterial vaginosis: implications for epidemiology, diagnosis and treatment. Current Opinion in Infectious Diseases 2013 26 1 86 89
2. Rubens C. E., Raff H. V., Jackson J. C., Chi E. Y., Bielitzki J. T., Hillier S. L., Pathophysiology and histopathology of group B streptococcal sepsis in Macaca nemestrina primates induced after intraamniotic inoculation: evidence for bacterial cellular invasion. The Journal of Infectious Diseases 1991 164 2 320 330 2-s2.0-0025785379
3. Herting E., Gan X., Rauprich P., Jarstrand C., Robertson B., Combined treatment with surfactant and specific immunoglobulin reduces bacterial proliferation in experimental neonatal group B streptococcal pneumonia. American Journal of Respiratory and Critical Care Medicine 1999 159 6 1862 1867 2-s2.0-0033033680 (Pubitemid 29275055)
4. Black R. E., Cousens S., Johnson H. L., Lawn J. E., Rudan I., Bassani D. G., Jha P., Campbell H., Walker C. F., Cibulskis R., Eisele T., Liu L., Mathers C., Global, regional, and national causes of child mortality in 2008: a systematic analysis. The Lancet 2010 375 9730 1969 1987 2-s2.0-77953002425 10.1016/S0140-6736(10)60549-1
5. Kochanek K. D., Xu J., Murphy S. L., Mininö A. M., Kung H.-C., Deaths: final data for 2009. National Vital Statistics Reports 2012 60 3 1 95
6. Stoll B. J., The global impact of neonatal infection. Clinics in Perinatology 1997 24 1 1 21 2-s2.0-0030888030 (Pubitemid 27180772)
7. Libster R., Edwards K. M., Levent F., Long-term outcomes of group B streptococcal meningitis. Pediatrics 2012 130 1 8 15
8. Ehrlich P., Diskussion waehrend der Gesellschaft der Charite Aerzte. Klinische Medizin 1898 35, article 273
9. Pokorny A., Birkbeck T. H., Almeida P. F. F., Mechanism and kinetics of δ -lysin interaction with phospholipid vesicles. Biochemistry 2002 41 36 11044 11056 2-s2.0-0036712127 10.1021/bi020244r (Pubitemid 35001219)
10. Freer J. H., Arbuthnott J. P., Toxins of Staphylococcus aureus. Pharmacology and Therapeutics 1982 19 1 55 106 2-s2.0-0020285081 (Pubitemid 13126831)
11. Bernheimer A. W., Rudy B., Interactions between membranes and cytolytic peptides. Biochimica et Biophysica Acta 1986 864 1 123 141 2-s2.0-0022497150 (Pubitemid 16083733)
12. Alouf J. E., Bacterial protein toxins. An overview. Methods in Molecular Biology 2000 145 1 26 2-s2.0-0033660888
13. Law R. H. P., Lukoyanova N., Voskoboinik I., Caradoc-Davies T. T., Baran K., Dunstone M. A., D'Angelo M. E., Orlova E. V., Coulibaly F., Verschoor S., Browne K. A., Ciccone A., Kuiper M. J., Bird P. I., Trapani J. A., Saibil H. R., Whisstock J. C., The structural basis for membrane binding and pore formation by lymphocyte perforin. Nature 2010 468 7322 447 451 2-s2.0-78549267766 10.1038/nature09518
14. Hadders M. A., Beringer D. X., Gros P., Structure of C8 α -MACPF reveals mechanism of membrane attack in complement immune defense. Science 2007 317 5844 1552 1554 2-s2.0-34548670476 10.1126/science.1147103 (Pubitemid 47417434)
15. Rosado C. J., Buckle A. M., Law R. H. P., Butcher R. E., Kan W. T., Bird C. H., Ung K., Browne K. A., Baran K., Bashtannyk-Puhalovich T. A., Faux N. G., Wong W., Porter C. J., Pike R. N., Ellisdon A. M., Pearce M. C., Bottomley S. P., Emsley J., Smith A. I., Rossjohn J., Hartland E. L., Voskoboinik I., Trapani J. A., Bird P. I., Dunstone M. A., Whisstock J. C., A common fold mediates vertebrate defense and bacterial attack. Science 2007 317 5844 1548 1551 2-s2.0-34548666167 10.1126/science.1144706 (Pubitemid 47417433)
16. Tilley S. J., Orlova E. V., Gilbert R. J. C., Andrew P. W., Saibil H. R., Structural basis of pore formation by the bacterial toxin pneumolysin. Cell 2005 121 2 247 256 2-s2.0-17444405610 10.1016/j.cell.2005.02.033 (Pubitemid 40546392)
17. Gouaux E., Channel-forming toxins: tales of transformation. Current Opinion in Structural Biology 1997 7 4 566 573 2-s2.0-0030865151 10.1016/S0959-440X(97)80123-6 (Pubitemid 27371304)
18. Anderluh G., Lakey J. H., Disparate proteins use similar architectures to damage membranes. Trends in Biochemical Sciences 2008 33 10 482 490 2-s2.0-52949087550 10.1016/j.tibs.2008.07.004
19. Parker M. W., Feil S. C., Pore-forming protein toxins: from structure to function. Progress in Biophysics and Molecular Biology 2005 88 1 91 142 2-s2.0-9244241054 10.1016/j.pbiomolbio.2004.01.009 (Pubitemid 39547775)
20. Gilbert R. J. C., Pore-forming toxins. Cellular and Molecular Life Sciences 2002 59 5 832 844 2-s2.0-0036285870 10.1007/s00018-002-8471-1 (Pubitemid 34628244)
21. Anderluh G., Dalla Serra M., Viero G., Guella G., Maček P., Menestrina G., Pore formation by equinatoxin II, a eukaryotic protein toxin, occurs by induction of nonlamellar lipid structures. The Journal of Biological Chemistry 2003 278 46 45216 45223 2-s2.0-0242664967 10.1074/jbc.M305916200 (Pubitemid 37432655)
22. Gilbert R. J. C., Inactivation and activity of cholesterol-dependent cytolysins: what structural studies tell us. Structure 2005 13 8 1097 1106 2-s2.0-23444457403 10.1016/j.str.2005.04.019 (Pubitemid 41111478)
23. 2+ dependent endocytosis. Journal of Cell Biology 2008 180 5 905 914 2-s2.0-40849118150 10.1083/jcb.200708010 (Pubitemid 351398418)
24. Corrotte M., Fernandes M. C., Tam C., Andrews N. W., Toxin pores endocytosed during plasma membrane repair traffic into the lumen of MVBs for degradation. Traffic 2012 13 3 483 494
25. Tam C., Idone V., Devlin C., Fernandes M. C., Flannery A., He X., Schuchman E., Tabas I., Andrews N. W., Exocytosis of acid sphingomyelinase by wounded cells promotes endocytosis and plasma membrane repair. Journal of Cell Biology 2010 189 6 1027 1038 2-s2.0-77953576191 10.1083/jcb.201003053
26. Husmann M., Dersch K., Bobkiewicz W., Beckmann E., Veerachato G., Bhakdi S., Differential role of p38 mitogen activated protein kinase for cellular recovery from attack by pore-forming S. aureus α -toxin or streptolysin O. Biochemical and Biophysical Research Communications 2006 344 4 1128 1134 2-s2.0-33646166722 10.1016/j.bbrc.2006.03.241
27. Bischofberger M., Iacovache I., van der Goot F. G., Pathogenic pore-forming proteins: function and host response. Cell Host & Microbe 2012 12 3 266 275
28. Costa A., Gupta R., Signorino G., Activation of the NLRP3 inflammasome by group B streptococci. Journal of Immunology 1950 188 4 1953 1960
29. Mariathasan S., Weiss D. S., Newton K., McBride J., O'Rourke K., Roose-Girma M., Lee W. P., Weinrauch Y., Monack D. M., Dixit V. M., Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006 440 7081 228 232 2-s2.0-32944470765 10.1038/nature04515 (Pubitemid 43372102)
30. Hamon M. A., Cossart P., K+ efflux is required for histone H3 dephosphorylation by Listeria monocytogenes listeriolysin o and other pore-forming toxins. Infection and Immunity 2011 79 7 2839 2846 2-s2.0-79959431647 10.1128/IAI.01243-10
31. Craven R. R., Gao X., Allen I. C., Gris D., Wardenburg J. B., McElvania-TeKippe E., Ting J. P., Duncan J. A., Staphylococcus aureus α -hemolysin activates the NLRP3-inflammasome in human and mouse monocytic cells. PLoS ONE 2009 4 10 2-s2.0-70449360107 10.1371/journal.pone.0007446 e7446
32. Holzinger D., Gieldon L., Mysore V., Staphylococcus aureus Panton-Valentine leukocidin induces an inflammatory response in human phagocytes via the NLRP3 inflammasome. Journal of Leukocyte Biology 2012 92 5 1069 1081
33. Fluegge K., Supper S., Siedler A., Berner R., Serotype distribution of invasive group B streptococcal isolates in infants: results from a nationwide active laboratory surveillance study over 2 years in Germany. Clinical Infectious Diseases 2005 40 5 760 763 2-s2.0-15044349311 10.1086/427942 (Pubitemid 40381355)
34. Henneke P., Berner R., Interaction of neonatal phagocytes with group B streptococcus: recognition and response. Infection and Immunity 2006 74 6 3085 3095 2-s2.0-33646916265 10.1128/IAI.01551-05 (Pubitemid 43794497)
35. Hensler M. E., Liu G. Y., Sobczak S., Benirschke K., Nizet V., Heldt G. P., Virulence role of group B Streptococcus β -hemolysin/cytolysin in a neonatal rabbit model of early-onset pulmonary infection. The Journal of Infectious Diseases 2005 191 8 1287 1291 2-s2.0-17044377416 10.1086/428946
36. Reiss A., Braun J. S., Jäger K., Freyer D., Laube G., Bührer C., Felderhoff-Müser U., Stadelmann C., Nizet V., Weber J. R., Bacterial pore-forming cytolysins induce neuronal damage in a rat model of neonatal meningitis. The Journal of Infectious Diseases 2011 203 3 393 400 2-s2.0-79751480235 10.1093/infdis/jiq047
37. Pritzlaff C. A., Chang J. C. W., Kuo S. P., Tamura G. S., Rubens C. E., Nizet V., Genetic basis for the β -haemolytic/cytolytic activity of group B streptococcus. Molecular Microbiology 2001 39 2 236 247 2-s2.0-0035154927 10.1046/j.1365-2958.2001.02211.x (Pubitemid 32113498)
38. Tapsall J. W., Pigment production by Lancefield-group-B streptococci (Streptococcus agalactiae). Journal of Medical Microbiology 1986 21 1 75 81 2-s2.0-0022617555 (Pubitemid 16150094)
39. Liu G. Y., Doran K. S., Lawrence T., Turkson N., Puliti M., Tissi L., Nizet V., Sword and shield: linked group B streptococcal β -hemolysin/cytolysin and carotenoid pigment function to subvert host phagocyte defense. Proceedings of the National Academy of Sciences of the United States of America 2004 101 40 14491 14496 2-s2.0-5144229510 10.1073/pnas.0406143101 (Pubitemid 39346776)
40. Nizet V., Gibson R. L., Chi E. Y., Framson P. E., Hulse M., Rubens C. E., Group B streptococcal beta-hemolysin expression is associated with injury of lung epithelial cells. Infection and Immunity 1996 64 9 3818 3826 2-s2.0-0029736682 (Pubitemid 26298710)
41. Nizet V., Gibson R. L., Rubens C. E., The role of group B streptococci β -hemolysin expression in newborn lung injury. Advances in Experimental Medicine and Biology 1997 418 627 630 2-s2.0-0030819130 (Pubitemid 27438508)
42. Gibson R. L., Nizet V., Rubens C. E., Group B streptococcal β -hemolysin promotes injury of lung microvascular endothelial cells. Pediatric Research 1999 45 5, part 1 626 634 2-s2.0-0032909112 (Pubitemid 29203591)
43. Nizet V., Kim K. S., Stins M., Jonas M., Chi E. Y., Nguyen D., Rubens C. E., Invasion of brain microvascular endothelial cells by group B streptococci. Infection and Immunity 1997 65 12 5074 5081 2-s2.0-1842372721 (Pubitemid 27513552)
44. Rubens C. E., Wessels M. R., Kuypers J. M., Kasper D. L., Weiser J. N., Molecular analysis of two group B streptococcal virulence factors. Seminars in Perinatology 1990 14 4, supplement 1 22 29 2-s2.0-0025039944 (Pubitemid 20256996)
45. Bebien M., Hensler M. E., Davanture S., The pore-forming toxin β hemolysin/cytolysin triggers p38 MAPK-dependent IL-10 production in macrophages and inhibits innate immunity. PLoS Pathogens 2012 8 7 100281
46. Ring A., Depnering C., Pohl J., Nizet V., Shenep J. L., Stremmel W., Synergistic action of nitric oxide release from murine macrophages caused by group B streptococcal cell wall and β -hemolysin/cytolysin. The Journal of Infectious Diseases 2002 186 10 1518 1521 2-s2.0-0037111032 10.1086/344895 (Pubitemid 35286125)
47. Lang S., Palmer M., Characterization of Streptococcus agalactiae CAMP factor as a pore-forming toxin. The Journal of Biological Chemistry 2003 278 40 38167 38173 2-s2.0-0141755375 10.1074/jbc.M303544200 (Pubitemid 37221704)
48. Lang S., Xue J., Guo Z., Palmer M., Streptococcus agalactiae CAMP factor binds to GPI-anchored proteins. Medical Microbiology and Immunology 2007 196 1 1 10 2-s2.0-33846664997 10.1007/s00430-006-0021-2 (Pubitemid 46197379)
49. Christie R., Atkins N. E., Munch-Petersen E., A note on a lytic phenomenon shown by group B streptococci. The Australian Journal of Experimental Biology and Medical Science 1944 22 197 200
50. Hensler M. E., Quach D., Hsieh C. J., Doran K. S., Nizet V., CAMP factor is not essential for systemic virulence of Group B Streptococcus. Microbial Pathogenesis 2008 44 1 84 88 2-s2.0-36849023169 10.1016/j.micpath.2007.08.005 (Pubitemid 350236692)
51. Hamon M. A., Ribet D., Stavru F., Cossart P., Listeriolysin O: the Swiss army knife of Listeria. Trends in Microbiology 2012 20 8 360 368
52. Portnoy D. A., Jacks P. S., Hinrichs D. J., Role of hemolysin for the intracellular growth of Listeria monocytogenes. Journal of Experimental Medicine 1988 167 4 1459 1471 2-s2.0-0023898917
53. Kathariou S., Metz P., Hof H., Goebel W., Tn916-induced mutations in the hemolysin determinant affecting virulence of Listeria monocytogenes. Journal of Bacteriology 1987 169 3 1291 1297 2-s2.0-0023138737 (Pubitemid 17043401)
54. Poston R. M., Kurlander R. J., Cytokine expression in vivo during murine listeriosis: infection with live, virulent bacteria is required for monokine and lymphokine messenger RNA accumulation in the spleen. Journal of Immunology 1992 149 9 3040 3044 2-s2.0-0026713768
55. Melton-Witt J. A., McKay S. L., Portnoy D. A., Development of a single-gene, signature-tag-based approach in combination with alanine mutagenesis to identify listeriolysin O residues critical for the in vivo survival of Listeria monocytogenes. Infection and Immunity 2012 80 6 2221 2230
56. Rossjohn J., Gilbert R. J. C., Crane D., Morgan P. J., Mitchell T. J., Rowe A. J., Andrew P. W., Paton J. C., Tweten R. K., Parker M. W., The molecular mechanism of pneumolysin, a virulence factor from Streptococcus pneumoniae. Journal of Molecular Biology 1998 284 2 449 461 2-s2.0-13144275228 10.1006/jmbi.1998.2167 (Pubitemid 28542465)
57. Rossjohn J., Feil S. C., McKinstry W. J., Tweten R. K., Parker M. W., Structure of a cholesterol-binding, thiol-activated cytolysin and a model of its membrane form. Cell 1997 89 5 685 692 2-s2.0-0030666371 (Pubitemid 27516171)
58. Schuerch D. W., Wilson-Kubalek E. M., Tweten R. K., Molecular basis of listeriolysin O pH dependence. Proceedings of the National Academy of Sciences of the United States of America 2005 102 35 12537 12542 2-s2.0-24644522834 10.1073/pnas.0500558102 (Pubitemid 41266394)
59. Gilbert R. J. C., Jiménez J. L., Chen S., Tickle I. J., Rossjohn J., Parker M., Andrew P. W., Saibil H. R., Two structural transitions in membrane pore formation by pneumolysin, the pore-forming toxin of Streptococcus pneumoniae. Cell 1999 97 5 647 655 2-s2.0-0033612389 10.1016/S0092-8674(00) 80775-8 (Pubitemid 29256967)
60. Shatursky O., Heuck A. P., Shepard L. A., Rossjohn J., Parker M. W., Johnson A. E., Tweten R. K., The mechanism of membrane insertion for a cholesterol-dependent cytolysin: a novel paradigm for pore-forming toxins. Cell 1999 99 3 293 299 2-s2.0-0033615736 10.1016/S0092-8674(00)81660-8 (Pubitemid 29519908)
61. Shepard L. A., Heuck A. P., Hamman B. D., Rossjohn J., Parker M. W., Ryan K. R., Johnson A. E., Tweten R. K., Identification of a membrane-spanning domain of the thiol-activated pore-forming toxin Clostridium perfringens perfringolysin O: an α -helical to β -sheet transition identified by fluorescence spectroscopy. Biochemistry 1998 37 41 14563 14574 2-s2.0-0032514655 10.1021/bi981452f (Pubitemid 28489065)
62. Dowd K. J., Tweten R. K., The cholesterol-dependent cytolysin signature motif: a critical element in the allosteric pathway that couples membrane binding to pore assembly. PLoS Pathogens 2012 8 7 100278
63. Bhakdi S., Tranum-Jensen J., Sziegoleit A., Mechanism of membrane damage by streptolysin-O. Infection and Immunity 1985 47 1 52 60 2-s2.0-0021971199 (Pubitemid 15194590)
64. Palmer M., Vulicevic I., Saweljew P., Valeva A., Kehoe M., Bhakdi S., Streptolysin O: a proposed model of allosteric interaction between a pore-forming protein and its target lipid bilayer. Biochemistry 1998 37 8 2378 2383 2-s2.0-0032562167 10.1021/bi9720890 (Pubitemid 28119312)
65. Czajkowsky D. M., Hotze E. M., Shao Z., Tweten R. K., Vertical collapse of a cytolysin prepore moves its transmembrane β -hairpins to the membrane. EMBO Journal 2004 23 16 3206 3215 2-s2.0-4444291857 10.1038/sj.emboj.7600350 (Pubitemid 39209145)
66. Jacobs T., Darji A., Frahm N., Rohde M., Wehland J., Chakraborty T., Weiss S., Listeriolysin O: cholesterol inhibits cytolysis but not binding to cellular membranes. Molecular Microbiology 1998 28 6 1081 1089 2-s2.0-0031776879 10.1046/j.1365-2958.1998.00858.x (Pubitemid 28293534)
67. Tilney L. G., Portnoy D. A., Actin filaments and the growth, movement, and spread of the intracellular bacterial parasite, Listeria monocytogenes. Journal of Cell Biology 1989 109 4, part 1 1597 1608 2-s2.0-0024741693
68. Gedde M. M., Higgins D. E., Tilney L. G., Portnoy D. A., Role of listeriolysin O in cell-to-cell spread of Listeria monocytogenes. Infection and Immunity 2000 68 2 999 1003 2-s2.0-0033977538 10.1128/IAI.68.2.999-1003.2000 (Pubitemid 30056571)
69. Singh R., Jamieson A., Cresswell P., GILT is a critical host factor for Listeria monocytogenes infection. Nature 2008 455 7217 1244 1247 2-s2.0-55249111793 10.1038/nature07344
70. Bernheimer H. P., Tiraby J. G., Inhibition of phage infection by pneumococcus capsule. Virology 1976 73 1 308 309 2-s2.0-0017130648
71. Smyth C. J., Duncan J. A., Jeljaszewicz J., Wadstrom T., Thiol-activated cytolysins. Bacterial ToxIns and Cell Membranes 1978 New York, NY, USA Academic Press 129 183
72. Radtke A. L., Anderson K. L., Davis M. J., DiMagno M. J., Swanson J. A., O'Riordan M. X., Listeria monocytogenes exploits cystic fibrosis transmembrane conductance regulator (CFTR) to escape the phagosome. Proceedings of the National Academy of Sciences of the United States of America 2011 108 4 1633 1638 2-s2.0-79952163545 10.1073/pnas.1013262108
73. Lam G. Y., Fattouh R., Muise A. M., Grinstein S., Higgins D. E., Brumell J. H., Listeriolysin O suppresses phospholipase C-mediated activation of the microbicidal NADPH oxidase to promote Listeria monocytogenes infection. Cell Host & Microbe 2011 10 6 627 634
74. Vadia S., Arnett E., Haghighat A. C., Wilson-Kubalek E. M., Tweten R. K., Seveau S., The pore-forming toxin listeriolysin O mediates a novel entry pathway of L. monocytogenes into human hepatocytes. PLoS Pathogens 2011 7 11 e1002356
75. Glomski I. J., Gedde M. M., Tsang A. W., Swanson J. A., Portnoy D. A., The Listeria monocytogenes hemolysin has an acidic pH optimum to compartmentalize activity and prevent damage to infected host cells. Journal of Cell Biology 2002 156 6 1029 1038 2-s2.0-0037128936 10.1083/jcb.200201081 (Pubitemid 34839852)
76. Bavdek A., Gekara N. O., Priselac D., Aguirre I. G., Darji A., Chakraborty T., Maček P., Lakey J. H., Weisse S., Anderluh G., Sterol and pH interdependence in the binding, oligomerization, and pore formation of listeriolysin O. Biochemistry 2007 46 14 4425 4437 2-s2.0-34147148578 10.1021/bi602497g (Pubitemid 46559408)
77. Bavdek A., Kostanjšek R., Antonini V., pH dependence of listeriolysin O aggregation and pore-forming ability. The FEBS Journal 2012 279 1 126 141
78. Dramsi S., Cossart P., Listeriolysin O-mediated calcium influx potentiates entry of Listeria monocytogenes into the human Hep-2 epithelial cell line. Infection and Immunity 2003 71 6 3614 3618 2-s2.0-0038780809 10.1128/IAI.71.6.3614-3618.2003 (Pubitemid 36637592)
79. 2+ oscillations. Cellular Microbiology 2002 4 8 483 491 2-s2.0-0036669958 10.1046/j.1462-5822.2002.00207.x (Pubitemid 34993747)
80. Malley R., Henneke P., Morse S. C., Cieslewicz M. J., Lipsitch M., Thompson C. M., Kurt-Jones E., Paton J. C., Wessels M. R., Golenbock D. T., Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proceedings of the National Academy of Sciences of the United States of America 2003 100 4 1966 1971 2-s2.0-0037452778 10.1073/pnas.0435928100 (Pubitemid 36254557)
81. Jin M. P., Ng V. H., Maeda S., Rest R. F., Karin M., Anthrolysin O and other gram-positive cytolysins are toll-like receptor 4 agonists. Journal of Experimental Medicine 2004 200 12 1647 1655 2-s2.0-11844262784 10.1084/jem.20041215 (Pubitemid 40094188)
82. Gekara N. O., Dietrich N., Lyszkiewicz M., Lienenklaus S., Weiss S., Signals triggered by a bacterial pore-forming toxin contribute to toll-like receptor redundancy in gram-positive bacterial recognition. The Journal of Infectious Diseases 2009 199 1 124 133 2-s2.0-58749090209 10.1086/595562
83. Gekara N. O., Jacobs T., Chakraborty T., Weiss S., The cholesterol-dependent cytolysin listeriolysin O aggregates rafts via oligomerization. Cellular Microbiology 2005 7 9 1345 1356 2-s2.0-23844478566 10.1111/j.1462-5822.2005.00561.x (Pubitemid 41179426)
84. Gekara N. O., Zietara N., Geffers R., Weiss S., Listeria monocytogenes induces T cell receptor unresponsiveness through pore-forming toxin listeriolysin O. The Journal of Infectious Diseases 2010 202 11 1698 1707 2-s2.0-78649593376 10.1086/657145
85. McCracken G. H. Jr., Shinefield H. R., Changes in the pattern of neonatal septicemia and meningitis. American Journal of Diseases of Children 1966 112 1 33 39 2-s2.0-0013923115
86. Harrison L. M., Morris J. A., Telford D. R., Brown S. M., Jones K., The nasopharyngeal bacterial flora in infancy: effects of age, gender, season, viral upper respiratory tract infection and sleeping position. FEMS Immunology and Medical Microbiology 1999 25 1-2 19 28 2-s2.0-0033057301 10.1016/S0928-8244(99) 00068-1 (Pubitemid 29317553)
87. Brosnahan A. J., Schlievert P. M., Gram-positive bacterial superantigen outside-in signaling causes toxic shock syndrome. The FEBS Journal 2011 278 23 4649 4667
88. Arad G., Levy R., Nasie I., Binding of superantigen toxins into the CD28 homodimer interface is essential for induction of cytokine genes that mediate lethal shock. PLoS Biology 2011 9 9 e1001149
89. Ramu Y., Xu Y., Lu Z., Inhibition of CFTR Cl- channel function caused by enzymatic hydrolysis of sphingomyelin. Proceedings of the National Academy of Sciences of the United States of America 2007 104 15 6448 6453 2-s2.0-34547540502 10.1073/pnas.0701354104 (Pubitemid 47186114)
90. Bhakdi S., Grimminger F., Suttorp N., Walmrath D., Seeger R., Proteinaceous bacterial toxins and pathogenesis of sepsis syndrome and septic shock: the unknown connection. Medical Microbiology and Immunology 1994 183 3 119 144 2-s2.0-0028106748 (Pubitemid 24266106)
91. Plummer R., Bodkin J., Yau T. W., Power D., Pantarat N., Larkin T. J., Szekely D., Bubb W. A., Sorrell T. C., Kuchel P. W., Modelling Staphylococcus aureus -induced septicemia using NMR. Magnetic Resonance in Medicine 2007 58 4 656 665 2-s2.0-35048903975 10.1002/mrm.21392 (Pubitemid 47556871)
92. Ji Y., Marra A., Rosenberg M., Woodnutt G., Regulated antisense RNA eliminates alpha-toxin virulence in Staphylococcus aureus infection. Journal of Bacteriology 1999 181 21 6585 6590 2-s2.0-0032728823 (Pubitemid 29517970)
93. Kernodle D. S., Voladri R. K. R., Menzies B. E., Hager C. C., Edwards K. M., Expression of an antisense hla fragment in Staphylococcus aureus reduces alpha-toxin production in vitro and attenuates lethal activity in a murine model. Infection and Immunity 1997 65 1 179 184 2-s2.0-0031022928 (Pubitemid 27008920)
94. Kebaier C., Chamberland R. R., Allen I. C., Staphylococcus aureus alpha-hemolysin mediates virulence in a murine model of severe pneumonia through activation of the NLRP3 inflammasome. The Journal of Infectious Diseases 2012 205 5 807 817
95. Ragle B. E., Bubeck Wardenburg J., Anti-alpha-hemolysin monoclonal antibodies mediate protection against Staphylococcus aureus pneumonia. Infection and Immunity 2009 77 7 2712 2718 2-s2.0-67650079244 10.1128/IAI.00115-09
96. Menzies B. E., Kernodle D. S., Passive immunization with antiserum to a nontoxic alpha-toxin mutant from Staphylococcus aureus is protective in a murine model. Infection and Immunity 1996 64 5 1839 1841 2-s2.0-0029986936 (Pubitemid 26129845)
97. Jonsson P., Lindberg M., Haraldsson I., Wadstrom T., Virulence of Staphylococcus aureus in a mouse mastitis model: studies of alpha hemolysin, coagulase, and protein A as possible virulence determinants with protoplast fusion and gene cloning. Infection and Immunity 1985 49 3 765 769 2-s2.0-0021826759 (Pubitemid 15021542)
98. Kielian T., Cheung A., Hickey W. F., Diminished virulence of an alpha-toxin mutant of Staphylococcus aureus in experimental brain abscesses. Infection and Immunity 2001 69 11 6902 6911 2-s2.0-0034783704 10.1128/IAI.69.11.6902-6911.2001 (Pubitemid 32995450)
99. Callegan M. C., Engel L. S., Hill J. M., O'Callaghan R. J., Corneal virulence of Staphylococcus aureus: roles of alpha-toxin and protein A in pathogenesis. Infection and Immunity 1994 62 6 2478 2482 2-s2.0-0028200916 (Pubitemid 24157079)
100. Song L., Hobaugh M. R., Shustak C., Cheley S., Bayley H., Gouaux J. E., Structure of staphylococcal α -hemolysin, a heptameric transmembrane pore. Science 1996 274 5294 1859 1866 2-s2.0-0030447720 10.1126/science.274.5294.1859 (Pubitemid 26424757)
101. McElroy M. C., Harty H. R., Hosford G. E., Boylan G. M., Pittet J. F., Foster T. J., Alpha-toxin damages the air-blood barrier of the lung in a rat model of Staphylococcus aureus -induced pneumonia. Infection and Immunity 1999 67 10 5541 5544 2-s2.0-0032858909 (Pubitemid 29455343)
102. Wilke G. A., Bubeck Wardenburg J., Role of a disintegrin and metalloprotease 10 in Staphylococcus aureus α -hemolysin-mediated cellular injury. Proceedings of the National Academy of Sciences of the United States of America 2010 107 30 13473 13478 2-s2.0-77955783248 10.1073/pnas.1001815107
103. Inoshima I., Inoshima N., Wilke G. A., A Staphylococcus aureus pore-forming toxin subverts the activity of ADAM10 to cause lethal infection in mice. Nature Medicine 2011 17 10 1310 1314
104. Hruz P., Zinkernagel A. S., Jenikova G., Botwin G. J., Hugot J. P., Karin M., Nizet V., Eckmann L., NOD2 contributes to cutaneous defense against Staphylococcus aureus through α -toxin-dependent innate immune activation. Proceedings of the National Academy of Sciences of the United States of America 2009 106 31 12873 12878 2-s2.0-69149087051 10.1073/pnas.0904958106
105. Gravet A., Colin D. A., Keller D., Giradot R., Monteil H., Prévost G., Characterization of a novel structural member, LukE-LukD, of the bi-component staphylococcal leucotoxins family. FEBS Letters 1998 436 2 202 208 2-s2.0-0032476021 10.1016/S0014-5793(98)01130-2 (Pubitemid 28468556)
106. Cooney J., Kienle Z., Foster T. J., O'Toole P. W., The gamma-hemolysin locus of Staphylococcus aureus comprises three linked genes, two of which are identical to the genes for the F and S components of leukocidin. Infection and Immunity 1993 61 2 768 771 2-s2.0-0027459158 (Pubitemid 23030872)
107. Wright J., Staphylococcal leucocidin (Neisser-Wechsberg type) and antileucociddin. The Lancet 1936 227 5879 1002 1005 2-s2.0-0005851630
108. Labandeira-Rey M., Couzon F., Boisset S., Brown E. L., Bes M., Benito Y., Barbu E. M., Vazquez V., Höök M., Etienne J., Vandenesch F., Bowden M. G., Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 2007 315 5815 1130 1133 2-s2.0-33847309856 10.1126/science.1137165 (Pubitemid 46328024)
109. Lipinska U., Hermans K., Meulemans L., Dumitrescu O., Badiou C., Duchateau L., Haesebrouck F., Etienne J., Lina G., Panton-Valentine leukocidin does play a role in the early stage of Staphylococcus aureus skin infections: a rabbit model. PLoS ONE 2011 6 8 2-s2.0-79961136139 10.1371/journal.pone.0022864 e22864
110. Zivkovic A., Sharif O., Stich K., Doninger B., Biaggio M., Colinge J., Bilban M., Mesteri I., Hazemi P., Lemmens-Gruber R., Knapp S., TLR 2 and CD14 mediate innate immunity and lung inflammation to staphylococcal panton-valentine leukocidin in vivo. Journal of Immunology 2011 186 3 1608 1617 2-s2.0-79251555968 10.4049/jimmunol.1001665
111. Alonzo F., Benson M. A., Chen J., Novick R. P., Shopsin B., Torres V. J., Staphylococcus aureus leucocidin ED contributes to systemic infection by targeting neutrophils and promoting bacterial growth in vivo. Molecular Microbiology 2012 83 2 423 435
112. Alonzo F., Kozhaya L., Rawlings S. A., CCR5 is a receptor for Staphylococcus aureus leukotoxin ED. Nature 2013 493 7430 51 55
113. Olson R., Nariya H., Yokota K., Kamio Y., Gouaux E., Crystal structure of staphylococcal lukF delineates conformational changes accompanying formation of a transmembrane channel. Nature Structural Biology 1999 6 2 134 140 2-s2.0-0032932083 10.1038/5821 (Pubitemid 29069775)
114. Pédelacq J. D., Maveyraud L., Prévost G., Baba-Moussa L., González A., Courcelle E., Shepard W., Monteil H., Samama J. P., Mourey L., The structure of a Staphylococcus aureus leucocidin component (LukF-PV) reveals the fold of the water-soluble species of a family of transmembrane pore-forming toxins. Structure 1999 7 3 277 287 2-s2.0-0033103175 10.1016/S0969-2126(99)80038-0 (Pubitemid 29159687)
115. Guillet V., Roblin P., Werner S., Coraiola M., Menestrina G., Monteil H., Prévost G., Mourey L., Crystal structure of leucotoxin S component: new insight into the staphylococcal β -barrel pore-forming toxins. The Journal of Biological Chemistry 2004 279 39 41028 41037 2-s2.0-4644355909 10.1074/jbc.M406904200 (Pubitemid 39287704)
116. Yamashita K., Kawai Y., Tanaka Y., Crystal structure of the octameric pore of staphylococcal γ -hemolysin reveals the β -barrel pore formation mechanism by two components. Proceedings of the National Academy of Sciences of the United States of America 2011 108 42 17314 17319
117. Meyer F., Girardot R., Piémont Y., Prévost G., Colin D. A., Analysis of the specificity of panton-valentine leucocidin and gamma-hemolysin F component binding. Infection and Immunity 2009 77 1 266 273 2-s2.0-58449091019 10.1128/IAI.00402-08
118. Szmigielski S., Sobiczewska E., Prévost G., Monteil H., Colin D. A., Jeljaszewicz J., Effect of purified staphylococcal leukocidal toxins on isolated blood polymorphonuclear leukocytes and peritoneal macrophages in vitro. Zentralblatt fur Bakteriologie 1998 288 3 383 394 2-s2.0-0032214423 (Pubitemid 29014600)
119. Weston E. J., Pondo T., Lewis M. M., The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008. The Pediatric Infectious Disease Journal 2011 30 11 937 941
120. Shane A. L., Stoll B. J., Recent developments and current issues in the epidemiology, diagnosis, and management of bacterial and fungal neonatal sepsis. American Journal of Perinatology 2013 30 2 131 141
121. Stoll B. J., Hansen N., Fanaroff A. A., Wright L. L., Carlo W. A., Ehrenkranz R. A., Lemons J. A., Donovan E. F., Stark A. R., Tyson J. E., Oh W., Bauer C. R., Korones S. B., Shankaran S., Laptook A. R., Stevenson D. K., Papile L. A., Kenneth Poole W., Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. The New England Journal of Medicine 2002 347 4 240 247 2-s2.0-0037173469 10.1056/NEJMoa012657 (Pubitemid 34787630)
122. Wiles T. J., Mulvey M. A., The RTX pore-forming toxin α -hemolysin of uropathogenic Escherichia coli: progress and perspectives. Future Microbiology 2013 8 73 84
123. Kaper J. B., Nataro J. P., Mobley H. L. T., Pathogenic Escherichia coli. Nature Reviews Microbiology 2004 2 2 123 140 2-s2.0-1842508193 10.1038/nrmicro818 (Pubitemid 39490066)
124. May A. K., Sawyer R. G., Gleason T., Whitworth A., Pruett T. L., In vivo cytokine response to Escherichia coli alpha-hemolysin determined with genetically engineered hemolytic and nonhemolytic E. coli variants. Infection and Immunity 1996 64 6 2167 2171 2-s2.0-0029995425 (Pubitemid 26167230)
125. Smith Y. C., Rasmussen S. B., Grande K. K., Conran R. M., O'Brien A. D., Hemolysin of uropathogenic Escherichia coli evokes extensive shedding of the uroepithelium and hemorrhage in bladder tissue within the first 24 hours after intraurethral inoculation of mice. Infection and Immunity 2008 76 7 2978 2990 2-s2.0-46449118617 10.1128/IAI.00075-08
126. Wiles T. J., Bower J. M., Redd M. J., Mulvey M. A., Use of zebrafish to probe the divergent virulence potentials and toxin requirements of extraintestinal pathogenic Escherichia coli. PLoS Pathogens 2009 5 12 2-s2.0-74549172457 10.1371/journal.ppat.1000697 e1000697
127. Bingen E., Picard B., Brahimi N., Mathy S., Desjardins P., Elion J., Denamur E., Phylogenetic analysis of Escherichia coli strains causing neonatal meningitis suggests horizontal gene transfer from a predominant pool of highly virulent B2 group strains. The Journal of Infectious Diseases 1998 177 3 642 650 2-s2.0-0031936736 (Pubitemid 28099878)
128. McCracken G. H. Jr., Sarff L. D., Glode M. P., Relation between Escherichia coli K1 capsular polysaccharide antigen and clinical outcome in neonatal meningitis. The Lancet 1974 2 7875 246 250 2-s2.0-0016255072
129. Guiral E., Bosch J., Vila J., Soto S. M., Prevalence of Escherichia coli among samples collected from the genital tract in pregnant and nonpregnant women: relationship with virulence. FEMS Microbiology Letters 2011 314 2 170 173 2-s2.0-78650215107 10.1111/j.1574-6968.2010.02160.x
130. Welch R. A., RTX toxin structure and function: a story of numerous anomalies and few analogies in toxin biology. Current Topics in Microbiology and Immunology 2001 257 85 111 2-s2.0-0034467679 (Pubitemid 32230026)
131. Baran K., Dunstone M., Chia J., Ciccone A., Browne K. A., Clarke C. J. P., Lukoyanova N., Saibil H., Whisstock J. C., Voskoboinik I., Trapani J. A., The molecular basis for perforin oligomerization and transmembrane pore assembly. Immunity 2009 30 5 684 695 2-s2.0-65549121526 10.1016/j.immuni.2009. 03.016
132. Bakás L., Veiga M. P., Soloaga A., Ostolaza H., Goñi F. M., Calcium-dependent conformation of E. coli α -haemolysin. Implications for the mechanism of membrane insertion and lysis. Biochimica et Biophysica Acta 1998 1368 2 225 234 2-s2.0-0032545776 10.1016/S0005-2736(97)00181-8 (Pubitemid 28031876)
133. Herlax V., Maté S., Rimoldi O., Bakás L., Relevance of fatty acid covalently bound to Escherichia coli -hemolysin and membrane microdomains in the oligomerization process. The Journal of Biological Chemistry 2009 284 37 25199 25210 2-s2.0-69949119994 10.1074/jbc.M109.009365
134. Benz R., Dobereiner A., Ludwig A., Goebel W., Haemolysin of Escherichia coli: comparison of pore-forming properties between chromosome and plasmid-encoded haemolysins. FEMS Microbiology Immunology 1992 105 1-3 55 62 2-s2.0-0026671837
135. Benz R., Schmid A., Wagner W., Goebel W., Pore formation by the Escherichia coli hemolysin: evidence for an association-dissociation equilibrium of the pore-forming aggregates. Infection and Immunity 1989 57 3 887 895 2-s2.0-0024505102 (Pubitemid 19064555)
136. Ludwig A., Benz R., Goebel W., Oligomerization of Escherichia coli haemolysin (HlyA) is involved in pore formation. Molecular and General Genetics 1993 241 1-2 89 96 2-s2.0-0027485301 (Pubitemid 23299209)
137. Bakás L., Chanturiya A., Herlax V., Zimmerberg J., Paradoxical lipid dependence of pores formed by the Escherichia coli α -hemolysin in planar phospholipid bilayer membranes. Biophysical Journal 2006 91 10 3748 3755 2-s2.0-33751232658 10.1529/biophysj.106.090019 (Pubitemid 44788317)
138. Skals M., Jorgensen N. R., Leipziger J., Praetorius H. A., α -hemolysin from Escherichia coli uses endogenous amplification through P2X receptor activation to induce hemolysis. Proceedings of the National Academy of Sciences of the United States of America 2009 106 10 4030 4035 2-s2.0-62649090086 10.1073/pnas.0807044106
139. Skals M., Leipziger J., Praetorius H. A., Haemolysis induced by α -toxin from Staphylococcus aureus requires P2X receptor activation. Pflügers Archiv: European Journal of Physiology 2011 462 5 669 679
140. Dhakal B. K., Mulvey M. A., The UPEC pore-forming toxin α -hemolysin triggers proteolysis of host proteins to disrupt cell adhesion, inflammatory, and survival pathways. Cell Host & Microbe 2012 11 1 58 69
141. Hilbert D. W., Clinical Escherichia coli isolates utilize alpha-hemolysin to inhibit in vitro epithelial cytokine production. Microbes and Infection / Institut Pasteur 2012 14 7-8 628 638
142. Cravioto A., Gross R. J., Scotland S. M., Rowe B., Mannose-resistant haemagglutination of human erythrocytes by strains of Escherichia coli from extraintestinal sources: lack of correlation with colonisation factor antigen (CFA/I). FEMS Microbiology Letters 1979 6 1 41 44 2-s2.0-0018671419 10.1016/0378-1097(79)90183-6 (Pubitemid 10238937)
143. Bian Z., Brauner A., Li Y., Normark S., Expression of and cytokine activation by Escherichia coli curli fibers in human sepsis. The Journal of Infectious Diseases 2000 181 2 602 612 2-s2.0-0034006823 10.1086/315233 (Pubitemid 30131828)
144. Evans D. J. Jr., Evans D. G., Hohne C., Hemolysin and K antigens in relation to serotype and hemagglutination type of M isolated from extraintestinal infections. Journal of Clinical Microbiology 1981 13 1 171 178 2-s2.0-0019365384 (Pubitemid 11176682)
145. McCabe W. R., Kaijser B., Olling S., Escherichia coli in bacteremia: K and O antigens and serum sensitivity of strains from adults and neonates. The Journal of Infectious Diseases 1978 138 1 33 41 2-s2.0-0018194467 (Pubitemid 8399825)
146. Ludwig A., Von Rhein C., Bauer S., Hüttinger C., Goebel W., Molecular analysis of cytolysin A (ClyA) in pathogenic Escherichia coli strains. Journal of Bacteriology 2004 186 16 5311 5320 2-s2.0-3843127450 10.1128/JB.186.16.5311-5320.2004 (Pubitemid 39038133)
147. Tourret J., Aloulou M., Garry L., Tenaillon O., Dion S., Ryffel B., Monteiro R. C., Denamur E., The interaction between a non-pathogenic and a pathogenic strain synergistically enhances extra-intestinal virulence in Escherichia coli. Microbiology 2011 157, part 3 774 785 2-s2.0-79952273362 10.1099/mic.0.037416-0
148. Wallace A. J., Stillman T. J., Atkins A., Jamieson S. J., Bullough P. A., Green J., Artymiuk P. J., E. coli hemolysin E (Hlye, ClyA, SheA): X-ray crystal structure of the toxin and observation of membrane pores by electron microscopy. Cell 2000 100 2 265 276 2-s2.0-0034695613 (Pubitemid 30064914)
149. Mueller M., Grauschopf U., Maier T., Glockshuber R., Ban N., The structure of a cytolytic α -helical toxin pore reveals its assembly mechanism. Nature 2009 459 7247 726 730 2-s2.0-66649132042 10.1038/nature08026
150. Pinheiro Da Silva F., Nizet V., Cell death during sepsis: integration of disintegration in the inflammatory response to overwhelming infection. Apoptosis 2009 14 4 509 521 2-s2.0-62449251424 10.1007/s10495-009-0320-3
151. Eitel J., Suttorp N., Opitz B., Innate immune recognition and inflammasome activation in listeria monocytogenes infection. Frontiers in Microbiology 2010 1, article 149
152. Perret M., Badiou C., Lina G., Cross-talk between Staphylococcus aureus leukocidins-intoxicated macrophages and lung epithelial cells triggers chemokine secretion in an inflammasome-dependent manner. Cellular Microbiology 2012 14 7 1019 1036
153. Ayres J. S., Trinidad N. J., Vance R. E., Lethal inflammasome activation by a multidrug-resistant pathobiont upon antibiotic disruption of the microbiota. Nature Medicine 2012 18 5 799 806
154. Imre G., Rajalingam K., Role for caspase-2 during pore-forming toxin-mediated apoptosis. Cell Cycle 2012 11 20 3709 3710
155. Imre G., Heering J., Takeda A. N., Caspase-2 is an initiator caspase responsible for pore-forming toxin-mediated apoptosis. EMBO Journal 2012 31 11 2615 2628
156. Genestier A. L., Michallet M. C., Prévost G., Bellot G., Chalabreysse L., Peyrol S., Thivolet F., Etienne J., Lina G., Vallette F. M., Vandenesch F., Genestier L., Staphylococcus aureus Panton-Valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils. The Journal of Clinical Investigation 2005 115 11 3117 3127 2-s2.0-27644538026 10.1172/JCI22684 (Pubitemid 41567576)
157. Carrero J. A., Unanue E. R., Mechanisms and immunological effects of apoptosis caused by Listeria monocytogenes. Advances in Immunology 2012 113 157 174
158. Fernandez-Prada C., Tall B. D., Elliott S. E., Hoover D. L., Nataro J. P., Venkatesan M. M., Hemolysin-positive enteroaggregative and cell-detaching Escherichia coli strains cause oncosis of human monocyte-derived macrophages and apoptosis of murine J774 cells. Infection and Immunity 1998 66 8 3918 3924 2-s2.0-0031824083 (Pubitemid 28347855)
159. Lai X. H., Arencibia I., Johansson A., Wai S. N., Oscarsson J., Kalfas S., Sundqvist K. G., Mizunoe Y., Sjöstedt A., Uhlin B. E., Cytocidal and apoptotic effects of the ClyA protein from Escherichia coli on primary and cultured monocytes and macrophages. Infection and Immunity 2000 68 7 4363 4367 2-s2.0-0033919438 10.1128/IAI.68.7.4363-4367.2000 (Pubitemid 30434600)
160. Rittirsch D., Flierl M. A., Ward P. A., Harmful molecular mechanisms in sepsis. Nature Reviews Immunology 2008 8 10 776 787 2-s2.0-52949118458 10.1038/nri2402
161. Stavru F., Bouillaud F., Sartori A., Ricquier D., Cossart P., Listeria monocytogenes transiently alters mitochondrial dynamics during infection. Proceedings of the National Academy of Sciences of the United States of America 2011 108 9 3612 3617 2-s2.0-79952749507 10.1073/pnas.1100126108
162. Hensler M. E., Miyamoto S., Nizet V., Group B streptococcal β -Hemolysin/cytolysin directly impairs cardiomyocyte viability and function. PLoS ONE 2008 3 6 2-s2.0-49349106807 10.1371/journal.pone.0002446 e2446
163. Malley R., Anderson P. W., Serotype-independent pneumococcal experimental vaccines that induce cellular as well as humoral immunity. Proceedings of the National Academy of Sciences of the United States 2012 109 10 3623 3627
164. Adhikari R. P., Karauzum H., Sarwar J., Novel structurally designed vaccine for S. aureus alpha-hemolysin: protection against bacteremia and pneumonia. PloS One 2012 7 6 e38567
165. Justin N., Walker N., Bullifent H. L., Songer G., Bueschel D. M., Jost H., Naylor C., Miller J., Moss D. S., Titball R. W., Basak A. K., The first strain of Clostridium perfringens isolated from an avian source has an alpha-toxin with divergent structural and kinetic properties. Biochemistry 2002 41 20 6253 6262 2-s2.0-0037150074 10.1021/bi012015v (Pubitemid 34525989)